ALK+ Lung Cancer Patients (English version)

This seminar provides information about the ALK+ lung cancer biomarker such as on-going research lines or treatments and patients' special needs. To do this, professionals and people affected from different countries tell us about their experiences and the latest scientific-medical developments and advances.

Moderator:
Anne-Marie Baird. President of Lung Cancer Europe (LuCE)

Speakers:
Prof. Dr. Sai-Hong Ignatius Ou. Health Science Clinical Professor Department of Medicine. UCI School of Medicine

Dr. Roberto Chiarle. Department of Pathology. Boston Children's Hospital

Dr. Jean-François Martini. Sr. Director, Translational Oncology Lead, Global Product Development. Pfizer Inc.

Dr. Glenn Broeckx. Department of Pathology. Antwerp University Hospital

Dr. Chiara Bennati. Medical Oncology. Ospedale Santa Maria delle Croci

Ms. Gina Hollenbeck. Lung cancer patient and president of ALK Positive

Organization:
AEACaP - http://afectadoscancerdepulmon.com/​
LuCE - https://www.lungcancereurope.eu/

Collaboration:
Pfizer - https://www.pfizer.es/
Takeda - https://www.takeda.com/es-es/